Genetic Landscape of Amyotrophic Lateral Sclerosis in Czech Patients

被引:0
|
作者
Baumgartner, Daniel [1 ,2 ]
Musova, Zuzana [2 ,3 ]
Zidkova, Jana [4 ,5 ]
Hedvicakova, Petra [2 ,3 ]
Vlckova, Eva [5 ,6 ]
Joppekova, Lubica [5 ,6 ]
Kramarova, Tereza [4 ,5 ]
Fajkusova, Lenka [4 ,5 ]
Stranecky, Viktor [7 ,8 ]
Geryk, Jan [2 ,3 ]
Votypka, Pavel [2 ,3 ]
Mazanec, Radim [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Med 2, Neuromuscular Ctr, Dept Neurol, 5Uvalu 84, Prague 15006, Czech Republic
[2] Univ Hosp Motol, 5Uvalu 84, Prague 15006, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Prague, Czech Republic
[4] Univ Hosp Brno, Masaryk Univ Brno, Ctr Mol Biol & Genet, Internal Haematol & Oncol Clin, Brno, Czech Republic
[5] Masaryk Univ Brno, Fac Med, Brno, Czech Republic
[6] Univ Hosp Brno, Masaryk Univ, Neuromuscular Ctr, Dept Neurol, Brno, Czech Republic
[7] Charles Univ Prague, Fac Med 1, Dept Pediat & Inherited Metab Disorders, Res Unit Rare Dis, Prague, Czech Republic
[8] Gen Univ Hosp, Prague, Czech Republic
关键词
Amyotrophic lateral sclerosis; neurogenetics; mutation screening; C9orf72 repeat expansion; next-generation sequencing; gene variants; GGGGCC HEXANUCLEOTIDE REPEAT; SPASTIN GENE; ALS; VARIANTS; ONSET; MUTATIONS; EXOME;
D O I
10.3233/JND-230236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Genetic factors are involved in the pathogenesis of familial and sporadic amyotrophic lateral sclerosis (ALS) and constitute a link to its association with frontotemporal dementia (FTD). Gene-targeted therapies for some forms of ALS (C9orf72, SOD1) have recently gained momentum. Genetic architecture in Czech ALS patients has not been comprehensively assessed so far. Objective: We aimed to deliver pilot data on the genetic landscape of ALS in our country. Methods: A cohort of patients with ALS (n n = 88), recruited from two Czech Neuromuscular Centers, was assessed for hexanucleotide repeat expansion (HRE) in C9orf72 and also for genetic variations in other 36 ALS-linked genes via next- generation sequencing (NGS). Nine patients (10.1%) had a familial ALS. Further, we analyzed two subgroups of sporadic patients - with concomitant FTD (n n =7) and with young-onset of the disease (n n = 22). Results: We detected the pathogenic HRE in C9orf72 in 12 patients (13.5%) and three other pathogenic variants in FUS, TARDBP and TBK1, each in one patient. Additional 7 novel and 9 rare known variants with uncertain causal significance have been detected in 15 patients. Three sporadic patients with FTD (42.9%) were harbouring a pathogenic variant (all HRE in C9orf72). Surprisingly, none of the young-onset sporadic patients harboured a pathogenic variant and we detected no pathogenic SOD1 variant in our cohort. Conclusion: Our findings resemble those from other European populations, with the highest prevalence of HRE in the C9orf72 gene. Further, our findings suggest a possibility of a missing genetic variability among young-onset patients.
引用
收藏
页码:1035 / 1048
页数:14
相关论文
共 50 条
  • [21] Brain metabolic signatures in patients with genetic and nongenetic amyotrophic lateral sclerosis
    Liu, Pan
    Tang, Yongxiang
    Li, Wanzhen
    Liu, Zhen
    Zhou, Ming
    Li, Jian
    Yuan, Yanchun
    Fang, Liangjuan
    Guo, Jifeng
    Shen, Lu
    Jiang, Hong
    Tang, Beisha
    Hu, Shuo
    Wang, Junling
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2530 - 2539
  • [22] Amyotrophic lateral sclerosis: recent genetic highlights
    White, Matthew A.
    Sreedharan, Jemeen
    CURRENT OPINION IN NEUROLOGY, 2016, 29 (05) : 557 - 564
  • [23] Genetic variability in sporadic amyotrophic lateral sclerosis
    Van Daele, Sien Hilde
    Moisse, Matthieu
    van Vugt, Joke J. F. A.
    Zwamborn, Ramona A. J.
    van der Spek, Rick
    van Rheenen, Wouter
    Van Eijk, Kristel
    Kenna, Kevin
    Corcia, Philippe
    Vourc'h, Patrick
    Couratier, Philippe
    Hardiman, Orla
    McLaughin, Russell
    Gotkine, Marc
    Drory, Vivian
    Ticozzi, Nicola
    Silani, Vincenzo
    Ratti, Antonia
    de Carvalho, Mamede
    Mora Pardina, Jesus S.
    Povedano, Monica
    Andersen, Peter M.
    Weber, Markus
    Basak, Nazli A.
    Shaw, Chris
    Shaw, Pamela J.
    Morrison, Karen E.
    Landers, John E.
    Glass, Jonathan D.
    van Es, Michael A.
    van den Berg, Leonard H.
    Al-Chalabi, Ammar
    Veldink, Jan
    Van Damme, Philip
    BRAIN, 2023, 146 (09) : 3760 - 3769
  • [24] Advances in the genetic classification of amyotrophic lateral sclerosis
    Cooper-Knock, Johnathan
    Harvey, Calum
    Zhang, Sai
    Moll, Tobias
    Timpanaro, Ilia Sarah
    Kenna, Kevin P.
    Iacoangeli, Alfredo
    Veldink, Jan H.
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (05) : 756 - 764
  • [25] Genetic and epigenetic studies of amyotrophic lateral sclerosis
    Al-Chalabi, Ammar
    Kwak, Shin
    Mehler, Mark
    Rouleau, Guy
    Siddique, Teepu
    Strong, Michael
    Leigh, Peter Nigel
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2013, 14 : 44 - 52
  • [26] Amyotrophic Lateral Sclerosis: A Genetic Point of View
    Carlesi, C.
    Ienco, E. Caldarazzo
    Mancuso, M.
    Siciliano, G.
    CURRENT MOLECULAR MEDICINE, 2014, 14 (08) : 1089 - 1101
  • [27] Extensive molecular genetic survey of Taiwanese patients with amyotrophic lateral sclerosis
    Soong, Bing-Wen
    Lin, Kon-Ping
    Guo, Yuh-Cherng
    Lin, Chou-Ching K.
    Tsai, Pei-Chien
    Liao, Yi-Chu
    Lu, Yi-Chun
    Wang, Shuu-Jiun
    Tsai, Ching-Piao
    Lee, Yi-Chung
    NEUROBIOLOGY OF AGING, 2014, 35 (10) : 2423.e1 - 2423.e6
  • [28] Genetic Rodent Models of Amyotrophic Lateral Sclerosis
    Van den Bosch, L.
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [29] Neurorehabilitation in patients with amyotrophic lateral sclerosis
    Liska, D.
    Brunn, D.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 (05) : 504 - 507
  • [30] Managing patients with amyotrophic lateral sclerosis
    Sathasivam, Sivakumar
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (04) : 355 - 358